Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bile acids for primary sclerosing cholangitis.

W Chen1, C Gluud

  • 1The Cochrane Hepato-Biliary Group, Copenhagen Trial Unit, H:S Rigshospitalet, Dept. 7102, Blegdamsvej 9, DK-2100 Copenhagen, Denmark. w.chen@ctu.rh.dk

The Cochrane Database of Systematic Reviews
|June 14, 2003
PubMed
Summary

Ursodeoxycholic acid improves liver biochemistry in primary sclerosing cholangitis patients but lacks evidence for clinical benefit. More high-quality trials are needed to confirm its effects.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The risks of adverse events with venlafaxine for adults with major depressive disorder: a systematic review of randomised clinical trials with meta-analysis and Trial Sequential Analysis.

Epidemiology and psychiatric sciences·2024
Same author

Tramadol for chronic pain in adults: protocol for a systematic review with meta-analysis and trial sequential analysis of randomised clinical trials.

Systematic reviews·2023
Same author

Effect of metformin and insulin vs. placebo and insulin on whole body composition in overweight patients with type 2 diabetes: a randomized placebo-controlled trial.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2021
Same author

[Glucocorticosteroids for people with alcoholic hepatitis (Cochrane review)].

Terapevticheskii arkhiv·2020
Same author

Ivabradine for coronary artery disease and/or heart failure-a protocol for a systematic review of randomised clinical trials with meta-analysis and Trial Sequential Analysis.

Systematic reviews·2019
Same author

The effect of metformin versus placebo in combination with insulin analogues on bone mineral density and trabecular bone score in patients with type 2 diabetes mellitus: a randomized placebo-controlled trial.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2018

Area of Science:

  • Hepatology
  • Gastroenterology
  • Clinical Trials

Background:

  • Bile acids are explored for treating primary sclerosing cholangitis (PSC).
  • The precise benefits and risks of bile acids in PSC remain uncertain.

Purpose of the Study:

  • To evaluate the efficacy and safety of bile acids in patients diagnosed with primary sclerosing cholangitis.
  • To synthesize evidence from randomized clinical trials on bile acid treatment for PSC.

Main Methods:

  • Searched multiple databases (Cochrane Hepato-Biliary Group, MEDLINE, EMBASE, etc.) up to May 2002.
  • Included randomized clinical trials comparing bile acids against placebo or no intervention.
  • Assessed trial quality and performed intention-to-treat analysis for outcomes.

Related Experiment Videos

Main Results:

  • Six low-quality trials (223 patients) were analyzed, primarily using ursodeoxycholic acid (UDCA).
  • UDCA did not significantly reduce mortality, treatment failure, or histological/cholangiographic deterioration.
  • UDCA significantly improved liver biochemistry markers including bilirubin and alkaline phosphatases, and was well-tolerated.

Conclusions:

  • Ursodeoxycholic acid demonstrates significant improvements in liver biochemistry for PSC patients.
  • Insufficient evidence exists to confirm or deny the clinical effectiveness of UDCA in PSC.
  • There is a critical need for large-scale, high-quality randomized clinical trials in PSC.